People
Désiré Collen
Physician, chemist and biotechnology entrepreneur whose KU Leuven research advanced tPA thrombolysis. He founded ThromboGenics and co-founded Fund+; LSRP’s current board directory and May2026 signed minutes confirm his chairmanship.
Roles
Life Sciences Research Partners
CurrentFounder and Board Chairman